Brain cancer

Our group work on Glioblastoma, an incurable form of brain cancer with the average survival rate of only 12-15 months post diagnosis.
This is largely due to the ability of these brain tumour cells to block the function of the immune system and thereby escape being killed by these immune cells. However, how these brain tumour cells inhibit the immune system is not completely known.
Our lab has a major focus to gain a better understanding of the methods used by brain tumour cells to suppress the immune system and how we can stop brain tumour cells from using these methods. This work will ultimately lead to superior treatment strategies for these patients and improve overall patient survival.
Group Leaders
  • Dr Rod Luwor
  • Dr Farrah Ahmady
PhD Candidates